FN2 Research
Markets, explained.
Cited, no-noise breakdowns of why stocks move — earnings reactions, macro shifts, and the data behind the headlines.
Oil Plunges, Tech Surges: Iran De-escalation Sparks a Risk-On Rally at the Edge of a Record
A 5-7% oil crash on Iran de-escalation, Amazon's $3 trillion milestone, and Palantir's 93% revenue growth drove the Nasdaq up 1.8% and the Dow to a fresh record. But with consumer sentiment at 49.5 and CPI still at 3.46%, the macro backdrop is mixed.
SpaceX Lockup Wave Meets Biotech IPO Surge: A Supply Test Begins
SpaceX's staggered lockup expirations could unleash 10x the shares sold at IPO, while four biotech listings price this week. Goldman Sachs says the supply-demand math gets harder in 2027 — and leveraged ETF plumbing adds a second layer of risk.
Markets Rally on Iran Pause, But Both Gulf Chokepoints Stay Shut
The Dow hit a record close and oil plunged after Trump canceled strikes on Iran. But both Gulf chokepoints remain shut, a sanctions bill threatens 100% tariffs on Russian oil buyers, and the yen needed its first joint US-Japan intervention since 1998.
SpaceX's $116 Billion Lockup Cliff: The Largest Supply Test in Modern Market History
SpaceX's August 6 lockup expiry releases ~911 million shares worth ~$116 billion — more than the company's entire current free float. It is the opening salvo in a year-long unlock schedule that collides with record US equity issuance, forcing investors to weigh supply absorption against $1.3 trillion in buybacks.
Oil Plunges on Trump's Hormuz Deal Claim — But Both Gulf Corridors Stay Shut
Brent crude fell 5% after Trump cancelled Iran strikes and claimed a Hormuz deal was near — but both Gulf shipping corridors remain shut, Iran denies talks, and global inventories are near stress levels. The eighth de-escalation rally since March faces the same physical reality that reversed every prior one.
Dow Record Close Belies a Fragile Setup: Iran Pause, Oil Plunge, and a Jobs Report That Could Redefine the Fed's Path
Oil's 5% plunge on Trump's Iran pause drove the Dow to a record close and sent Big Tech soaring. But chip-stock volatility, a 47% earnings beat rate, and Friday's jobs report leave the rally on thin ice.
Biotech IPOs Lead a Thin August Calendar While the SEC Rewrites Market Structure
August's US IPO calendar is sparse but biotech-heavy, with Attovia, Vogenx, and Braveheart Bio pricing $575 million combined. Meanwhile, the SEC's proposed rescission of Reg NMS Rule 611 and a September 24-hour trading roundtable could reshape the plumbing underneath every new listing.
Iran De-escalation Sparks Oil Rout and Risk-On Rally — But Both Gulf Straits Remain Shut
Markets rallied hard on Trump's Iran de-escalation, but both Gulf shipping straits remain effectively closed, 100% pharma tariffs just went live, and the US-Japan yen intervention signals currency stress the rally overlooks.
Nasdaq's 1.4% Lead Tells a Two-Catalyst Story: Oil Plunges on Iran De-escalation While Big Tech Surges on Cloud and AI Earnings
The Nasdaq leads all three major indexes higher on August 3 as Trump's call-off of Iran strikes sends oil down 6% and Big Tech post-earnings momentum from Meta, Amazon, Google, and Microsoft fuels a broad risk-on bid. But sticky inflation and cratering consumer sentiment complicate the bullish read.
IPO Window Opens on Two Tracks as SEC Rewrites Market Plumbing
Apnimed's 56% first-day surge and Jersey Mike's 6% discount reveal an issuer's market that rewards catalysts over brands. The SEC's proposal to rescind the Order Protection Rule and Nasdaq's December 23/5 trading launch quietly reshape the rails underneath.
The Hormuz Mirage: Markets Price a Peace Deal, But Both Gulf Shipping Lanes Stay Shut
Brent crude has slid $16 in eight sessions and US futures are green after Trump called off strikes on Iran, but Tehran denies direct talks, both Gulf shipping lanes remain effectively shut, and a fresh tanker incident underscores the gap between the diplomatic headline and the waterway.